Timothy Walker

603 POSTS 0 COMMENTS
Tim is a contributing analyst for EconomicCalendar.com and specializes in equities trading and public offerings. He is a graduate of UCLA and began his career doing capital markets research for a top investment banking software provider.
laboratory

Promising Glaucoma Trial Results Push Aerie Pharma (AERI) 39% Higher

Investors are clamoring to snap up shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) this morning. The biotech’s stock is currently trading about 39 percent higher...
laboratory

NovoCure (NVCR) Scores HUD Designation For Tumor-Slowing Device

Oncology therapeutics company NovoCure Ltd (NASDAQ:NVCR) is making some serious gains today, with its share price current at $13.53 in mid-afternoon trading – which...
laboratory

Inovio (INO) Skyrockets With Historic HIV Vaccine Results

Inovio Pharmaceuticals Inc (NASDAQ:INO) is flying high this morning, currently trading $1.60 higher at $8.73 – a 22 percent boost. The sudden surge comes...

EnteroMedics (ETRM) Snaps Up Gastric Vest Maker

Medical device maker EnteroMedics Inc (NASDAQ:ETRM) is trading considerably higher this morning, following the announcement that the company just acquired BarioSurg Inc – which...

4 Analysts Start Verona Pharma (VRNA) At Buy

Verona Pharma plc (NASDAQ:VRNA) has been making some serious gains today, currently sitting comfortably at $15.63 in late-afternoon trading – a $2.11, or 16...
scientist lab pharmaceutical

New ODAC Documents Drive Puma Biotech (PBYI) 35% Higher

Puma Biotechnology Inc (NASDAQ:PBYI) is soaring in mid-afternoon trading today, following a breaking news story regarding its not-yet-approved breast cancer drug, neratinib. The investigational...

Revance Therapeutics (RVNC) Spikes On New Phase 2 Efficacy Data

Revance Therapeutics Inc (NASDAQ:RVNC) is trading sharply higher today, currently up $1.60 and sitting comfortably at $20.95 – an eight percent boost. After the...
laboratory

GlycoMimetics (CLYC) Skyrockets On Breakthrough Therapy Designation

GlycoMimetics Inc (NASDAQ:GLYC) is absolutely soaring today, having already gained more than 103 percent since the market open. At the time of writing in...
laboratory

Cancer Drug Updates & Q1 Results Drive Immune Design (IMDZ) 8% Higher

Immune Design Corp (NASDAQ:IMDZ) is trading sharply higher today, currently at $6.55 – an increase of 50 cents, or eight percent, from yesterday’s closing...

Syndax Pharmaceuticals (SNDX) Surges As It Moves Into Phase 2

Syndax Pharmaceuticals Inc (NASDAQ:SNDX) is skyrocketing today, trading $3.02 higher at $12.41 – a 32 percent increase. After the market close yesterday, the company...

Upcoming Economic Events

Other News

NVIDIA (NVDA) Stock Spikes Extraordinarily, Is It a Selling Opportunity?

Nvidia's (NASDAQ:NVDA) stock price jumped massively over the last two weeks, surged from $105 to $140 a share, spurred by SoftBank's new stake of...

Micron Technology (MU): Buy and Hold For Robust Stock Price Appreciation

Improving demand for technological innovations and increasing digitalization trends have been moving tech stocks higher over the last twelve months. Micron Technology (NASDAQ:MU), a...
gold

Fed Caution Underpins Gold Prices, Buyers Unable To Make Headway

A cautious tone in the Federal Reserve minutes supported gold, although gains were limited as the dollar was able to show some underlying resilience...
laboratory

Promising Glaucoma Trial Results Push Aerie Pharma (AERI) 39% Higher

Investors are clamoring to snap up shares of Aerie Pharmaceuticals Inc (NASDAQ:AERI) this morning. The biotech’s stock is currently trading about 39 percent higher...

General Electric (GE) Stock Moves Into The Red, Why You Should Avoid It

General Electric's (NYSE:GE) share price extended the volatility, as the stock moves back to 52-weeks low just after touching the 52-week high of $33...
1,895FansLike
9,753FollowersFollow
1,340FollowersFollow